Division of Critical Care, Department of Medicine, Hôpital du Sacré-Cœur de Montréal, 5400 Boulevard Gouin Ouest, Montreal, QC, H4J 1C5, Canada.
Division of Critical Care, Department of Surgery, Montreal Heart Institute, Montreal, Canada.
Crit Care. 2022 Dec 5;26(1):375. doi: 10.1186/s13054-022-04249-w.
Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) can be used to restore organ perfusion in patients with cardiogenic shock until native heart recovery occurs. It may be challenging, however, to determine when patients can be weaned successfully from ECMO-surviving without requiring further mechanical support or heart transplant. We aimed to systematically review the medical literature to determine the biomarkers, hemodynamic and echocardiographic parameters associated with successful weaning of VA-ECMO in adults with cardiogenic shock and to present an evidence-based weaning algorithm incorporating key findings.
We systematically searched PubMed, Embase, ProQuest, Google Scholars, Web of Science and the Grey literature for pertinent original research reports. We excluded studies limited to extracorporeal cardiopulmonary resuscitation (ECPR) as the neurological prognosis may significantly alter the decision-making process surrounding the device removal in this patient population. Studies with a mixed population of VA-ECMO for cardiogenic shock or cardiac arrest were included. We excluded studies limited to patients in which ECMO was only used as a bridge to VAD or heart transplant, as such patients are, by definition, never "successfully weaned." We used the Risk of Bias Assessment tool for Non-Randomized Studies. The study was registered on the International prospective register of systematic reviews (PROSPERO CRD42020178641).
We screened 14,578 records and included 47 that met our pre-specified criteria. Signs of lower initial severity of shock and myocardial injury, early recovery of systemic perfusion, left and right ventricular recovery, hemodynamic and echocardiographic stability during flow reduction trial and/or pump-controlled retrograde trial off predicted successful weaning. The most widely used parameter was the left ventricular outflow tract velocity time integral, an indicator of stroke volume. Most studies had a moderate or high risk of bias. Heterogeneity in methods, timing, and conditions of measurements precluded any meta-analysis.
In adult patients on VA-ECMO for cardiogenic shock, multiple biomarkers, hemodynamic and echocardiographic parameters may be used to track resolution of systemic hypoperfusion and myocardial recovery in order to identify patients that can be successfully weaned.
静脉-动脉(VA)体外膜肺氧合(ECMO)可用于恢复心源性休克患者的器官灌注,直到原生心脏恢复。然而,确定患者何时可以成功脱离 ECMO 支持而无需进一步的机械支持或心脏移植可能具有挑战性。我们旨在系统地审查医学文献,以确定与心源性休克成人成功脱离 VA-ECMO 相关的生物标志物、血流动力学和超声心动图参数,并提出一个纳入关键发现的基于证据的脱机算法。
我们系统地检索了 PubMed、Embase、ProQuest、Google Scholar、Web of Science 和灰色文献中的相关原始研究报告。我们排除了仅将体外心肺复苏(ECPR)作为研究对象的研究,因为在这一患者群体中,神经预后可能会显著改变设备移除的决策过程。纳入了 VA-ECMO 用于心源性休克或心脏骤停的混合人群的研究。我们排除了仅将 ECMO 用作心脏辅助装置或心脏移植桥接的患者的研究,因为这些患者根据定义从未“成功脱机”。我们使用非随机研究风险评估工具。该研究已在国际前瞻性系统评价注册中心(PROSPERO CRD42020178641)注册。
我们筛选了 14578 条记录,纳入了符合我们预先指定标准的 47 条记录。较低的初始休克严重程度和心肌损伤迹象、全身灌注的早期恢复、左心室和右心室的恢复、在流量减少试验和/或泵控制逆行试验期间的血流动力学和超声心动图稳定性以及脱机预测成功的指标,如左心室流出道速度时间积分,是一个反映每搏量的指标。大多数研究存在中度或高度偏倚风险。由于方法、时间和测量条件的异质性,排除了任何荟萃分析。
在心源性休克接受 VA-ECMO 的成年患者中,多种生物标志物、血流动力学和超声心动图参数可用于跟踪全身灌注不足和心肌恢复的情况,以确定可以成功脱机的患者。